Oncology Trials: Strategic Site Partner

AbbVie; Sydney; On-site; AUD 180,000 - 240,000; Full time

Job summary

AbbVie seeks a Strategic Site Partner to manage partnerships with key investigative sites across solid tumour and haematology trials. You will drive site engagement, unlock capacity, remove barriers, and speed trial delivery through cross-functional collaboration with internal leaders.

Fostering strategic alliances, you will manage risks and ensure sites’ operational excellence while aligning AbbVie as a partner of choice in global trials.

Qualifications

• Bachelor's or higher in health care or scientific field preferred.
• Minimum of 10 years in clinical research with leadership experience.
• Broad understanding of global pharma/biotech; drug development knowledge.
• Strong communication skills with ability to influence and collaborate cross-functionally.
• Demonstrated leadership, problem solving and ability to manage complexity.

Responsibilities

• Develop site-specific engagement strategy for assigned sites.
• Build and manage relationships with investigative sites with a white-glove service approach.
• Proactively anticipate site needs and mitigate issues.
• Resolve complex operational issues with a solution-oriented mindset.
• Drive efficiencies and accelerate clinical trial execution across studies/programs.
• Oversee site performance metrics and quality; review forecasts and resource planning.

Skills

Stakeholder management

Cross-functional collaboration

Leadership

Analytical thinking

Communication skills

Influencing without authority

Education

Bachelor's degree or higher in health care/science

Job description

AbbVie seeks a Strategic Site Partner to manage partnerships with key investigative sites across solid tumour and haematology trials. You will drive site engagement, unlock capacity, remove barriers, and speed trial delivery through cross-functional collaboration with internal leaders.

Fostering strategic alliances, you will manage risks and ensure sites’ operational excellence while aligning AbbVie as a partner of choice in global trials.